Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Equity (Details)

v3.26.1
Stockholders' Equity (Details) - USD ($)
 12 Months Ended
Dec. 10, 2021
Nov. 12, 2021
Dec. 31, 2025
Sep. 30, 2025
Dec. 31, 2024
Feb. 21, 2022
Stockholders’ Equity [Line Items]            
Common stock, shares authorized     300,000,000   300,000,000  
Common stock, par value (in Dollars per share)     $ 0.0001   $ 0.0001  
Common stock, shares issued     18,508,157   18,598,574  
Common stock, shares outstanding     18,508,157   18,598,574  
Voting rights     one      
Preferred Stock, shares authorized     50,000,000   50,000,000  
Preferred Stock, par value (in Dollars per share)     $ 0.0001   $ 0.0001  
Number of warrants shares issued   4,987,951        
Exercise price (in Dollars per share) $ 4.97 $ 5.1875        
Warrant price percentage   125.00%        
Number of warrants to purchase common stock 131,158 149,639        
Number of warrants exercised     659,456      
Repurchase amount (in Dollars)       $ 147,000   $ 10,000,000
PIPE Warrants [Member]            
Stockholders’ Equity [Line Items]            
Number of warrants shares issued 5,464,903          
Exercise price (in Dollars per share) $ 4.97          
Warrant exercised (in Dollars)     $ 0      
Issued warrants     5,596,061      
IPO [Member]            
Stockholders’ Equity [Line Items]            
Exercise price (in Dollars per share) $ 4.81375 $ 5.1875